NCT04662736View on ClinicalTrials.gov

Tedizolid Suppressive Antimicrobial Therapy in a Reference Center

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

February 1, 2021

Study Completion Date

April 1, 2021

Conditions
Bone and Joint Infection
Interventions
OTHER

patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy

description of osteo-articular infection managed with tedizolid as a suppressive antibiotic therapy

Trial Locations (1)

69004

Hospices Civils de Lyon, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04662736 - Tedizolid Suppressive Antimicrobial Therapy in a Reference Center | Biotech Hunter | Biotech Hunter